FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Moore

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Jean-Philippe Julien; C Richter King; Per Johan Klasse; Jeong Hyun Lee; Andre J Marozsan; John P Moore; Charles D Murin; Rogier W Sanders; Michael J Caulfield; Albert Cupo; Ronald Derking; Simon Hoffenberg; Ian A Wilson; Andrew B Ward
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.
Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary Nabel; Joseph Sodroski; Ian A Wilson; Richard Wyatt
HIV vaccine design and the neutralizing antibody problem.
Michael B Zwick; Aran F Labrijn; Meng Wang; C Spenlehauer; Erica Ollmann Saphire; James M Binley; John P Moore; Gabriela Stiegler; Hermann Katinger; Dennis R Burton; Paul W H I Parren
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean-Philippe Julien; C Richter King; Per Johan Klasse; Jeong Hyun Lee; Andre J Marozsan; John P Moore; Charles D Murin; Rogier W Sanders; Michael J Caulfield; Albert Cupo; Ronald Derking; Simon Hoffenberg; Ian A Wilson; Andrew B Ward
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(11):4351-6.
2004: Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary Nabel; Joseph Sodroski; Ian A Wilson; Richard Wyatt
HIV vaccine design and the neutralizing antibody problem.
Nature immunology 2004;5(3):233-6.
2001: Michael B Zwick; Aran F Labrijn; Meng Wang; C Spenlehauer; Erica Ollmann Saphire; James M Binley; John P Moore; Gabriela Stiegler; Hermann Katinger; Dennis R Burton; Paul W H I Parren
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
Journal of virology 2001;75(22):10892-905.
2001: Paul W H I Parren; Preston A Marx; Ann J Hessell; Amara Luckay; Janet M Harouse; Cecilia Cheng-Mayer; John P Moore; Dennis R Burton
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.
Journal of virology 2001;75(17):8340-7.
1999: Paul W H I Parren; John P Moore; Dennis R Burton; Quentin J Sattentau
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
AIDS (London, England) 1999;13 Suppl A():S137-62.
1998: Paul W H I Parren; Meng Wang; Alexandra Trkola; James M Binley; M Purtscher; Hermann Katinger; John P Moore; Dennis R Burton
Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1.
Journal of virology 1998;72(12):10270-4.
1998: Dennis R Burton; John P Moore
Why do we not have an HIV vaccine and how can we make one? .
Nature medicine 1998;4(5 Suppl):495-8.
1997: Henrik J Ditzel; Paul W H I Parren; James M Binley; Joseph Sodroski; John P Moore; Carlos F Barbas; Dennis R Burton
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries.
Journal of molecular biology 1997;267(3):684-95.